← brief for 2026-09-25 · Slowing decline

Renal Function Decline After 177 Lu-PSMA-617 Versus Taxane-Based Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Propensity Score Analysis

Article C Peer reviewed Observational

Key takeaways

This study compared two cancer treatments and their effect on kidney function. It shows a link between the treatments and kidney changes, but it is not proof of cause. The study looked at people with prostate cancer.

Who did this work

Natasha Sheheryar (Mayo Clinic) · Yalda Nikanpour (Mayo Clinic) · Sandhya Manohar (Hypertension Institute) · Dan Childs (Mayo Clinic) · Gokce Belge Belgin (Mayo Clinic) · Robert McDonald (Mayo Clinic) · Jennifer McDonald (Mayo Clinic) · Matt P. Thorpe (Mayo Clinic) · Geoffrey B. Johnson (Mayo Clinic)

Source

Article · OpenAlex, CKD works · 2026-09-24
https://doi.org/10.2967/jnumed.126.272551